Lionco Pharmaceutical

Shanghai-based Lionco Pharmaceutical Group (SHA: 603669) has entered into a strategic partnership framework agreement with France’s Laboratoire Bailly-Creat, aiming to penetrate international markets. Under this collaboration, Lionco will manufacture GMP-compliant injection and solid preparation products from its portfolio at its Hainan manufacturing base for Bailly-Creat. The French company will take…